Cor Vasa 2021, 63(3):339-344 | DOI: 10.33678/cor.2020.098

Microscopical assessment of explanted allograft heart valves: a limited contribution of histopathology to the pathogenic mechanism of the graft failure in long-term explants

Ondřej Fabiána, b, c, Mariia Havovad, Roman Gebauere, Rudolf Porubane, Ondřej Maternae, Jaroslav Špatenkaf, Jan Burkertf, Václav Chaloupeckýe, Vilém Rohnd, Filip Mikušc, Eliška Obešlovác, Jan Janoušeke
a Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague
b Department of Pathology and Molecular Medicine, Thomayer Teaching Hospital, 3rd Faculty of Medicine, Charles University, Prague
c Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague
d Department of Cardiovascular Surgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague
e Children's Heart Centre, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague
f Transplant Centre, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague

Background: Cryopreserved allograft heart valves (CAHV) currently represent conduits of choice showing longer event-free survival compared to other types of prostheses. However, almost all patients develop early or late allograft failure. The exact mechanism of the failure and eventual role of cellular or antibody-mediated rejection remain uncertain. In this study, we targeted the microscopical structure of CAHV in correlation to the duration of implantation, assessed the degree of degenerative changes and searched for signs of cellular rejection.

Methods: 24 patients with CAHV and one patient with xenograft heart valve who required conduit explan-tation in the period of 11/2017–5/2020 were prospectively enrolled in the study. Age of the patients at the time of implantation, duration of implantation, type of conduit, main diagnosis and number of previous implantations were recorded. Conduits were subjected to light microscopy and the microscopic structure was assessed using basic staining methods and immunohistochemistry.

Results: All conduits were completely non-vital, with areas of necrosis, hyalinization, calcifi cation, meta-plastic bone formation and pannus overgrowth. Foci of rejection-type infl ammatory infi ltrate were noted in three cases. Three other patients showed perioperative and microscopical signs of subacute infective endocarditis. Both severity of the microscopical changes and presence of rejection-type infiltrate were inde-pendent of duration of implantation or any other clinical variable.

Conclusions: Histopathological assessment of explanted conduits may contribute to understanding of exact pathogenic mechanisms of allograft failure. However, the microscopic appearance of long-term explants is often non-specifi c and signs of cellular rejection are sparse. Examination of short-term and intermediate--term explants may be more beneficial.

Keywords: Allograft heart valve, Explantation, Failure, Histopathology, Rejection

Received: October 16, 2020; Revised: October 28, 2020; Accepted: October 28, 2020; Published: July 20, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fabián O, Havova M, Gebauer R, Poruban R, Materna O, Špatenka J, et al.. Microscopical assessment of explanted allograft heart valves: a limited contribution of histopathology to the pathogenic mechanism of the graft failure in long-term explants. Cor Vasa. 2021;63(3):339-344. doi: 10.33678/cor.2020.098.
Download citation

References

  1. Albert JD, Bishop DA, Fullerton DA, et al. Conduit Reconstruction of the Right Ventricular Outflow Tract. Lessons Learned in a Twelve-Year Experience. J Thorac Cardiovasc Surg 1993;106:228-236. Go to original source...
  2. Bielefeld MR, Bishop DA, Campbell DN et al. Reoperative Homograft Right Ventricular Outflow Tract Reconstruction. Ann Thorac Surg 2001;71:482-488. Go to original source... Go to PubMed...
  3. Tweddell JS, Pelech AN, Frommelt PC, et al. Factors Affecting Longevity of Homograft Valves Used in Right Ventricular Outflow Tract Reconstruction for Congenital Heart Disease. Circulation 2000;102(19 Suppl 3):III130-III135. Go to original source... Go to PubMed...
  4. Niwaya K, Knott-Craig CJ, Lane MM, et al. Cryopreserved Homograft Valves in the Pulmonary Position: Risk Analysis for Intermediate-Term Failure. J Thorac Cardiovasc Surg 1999;117:141-147. Go to original source... Go to PubMed...
  5. Baskett RJ, Ross DB, Nanton MA, et al. Factors in the Early Failure of Cryopreserved Homograft Pulmonary Valves in Children: Preserved Immunogenicity? J Thorac Cardiovasc Surg 1996;112:1170-1179. Go to original source... Go to PubMed...
  6. Kalfa DM, Loundou A, de Gorce YN, et al. Pulmonary Position Cryopreserved Homograft in non-Ross Patients: How to Improve the Results? Eur J Cardiothorac Surg 2012;42:981-987. Go to original source... Go to PubMed...
  7. Vogt PR, Stallmach T, Niederhäuser U, et al. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg 1999;15:639-645. Go to original source... Go to PubMed...
  8. Koolbergen D, Hazekamp MG, de Heer E, et al. The pathology of fresh and cryopreserved homograft heart valves: an analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg 2002;124:689-697. Go to original source... Go to PubMed...
  9. Cebotari S, Lichtenberg A, Tudorache I, et al. Clinical Application of Tissue Engineered Human Heart Valves
  10. Using Autologous Progenitor Cells. Circulation 2006;114(1 Suppl):I132-I137.
  11. Gellis L, Baird CW, Emani S, et al. Morphologic and histologic findings in bioprosthetic valves explanted from the mitral position in children younger than 5 years of age. J Thorac Cardiovasc Surg 2018;155:746-752. Go to original source... Go to PubMed...
  12. Neves J, Monteiro C, Santos R, et al. Histologic and genetic assessment of explanted allograft valves. Ann Thorac Surg 1995;60(2 Suppl):S141-S145. Go to original source... Go to PubMed...
  13. Krs O, Slizova D, Burkert J, et al. Impact of Processing on Surface Structure of Human Cardiac Valve Allografts. Acta Medica (Hradec Kralove) 2004;47:97-99. Go to original source...
  14. Burkert J, Krs O, Vojacek J, et al. Cryopreserved Semilunar Heart Valve Allografts: Leaflet Surface Damage in Scanning Electron Microscopy. Zentralbl Chir 2008;133:367-373. Go to original source... Go to PubMed...
  15. Goffin YA, de Gouveia RH, Szombathelyi T, et al. Morphologic Study of Homograft Valves before and after Cryopreservation and after Short-Term Implantation in Patients. Cardiovasc Pathol 1997;6:35-42. Go to original source... Go to PubMed...
  16. Lupinetti FM, Christy JP, King DM, et al. Immunogenicity, Antigenicity, and Endothelial Viability of Aortic Valves Preserved at 4°C in a Nutrient Medium. J Cardiol Surg 1991;6:454-461. Go to original source... Go to PubMed...
  17. O'Brien MF, Stafford EG, Gardner MAH, et al. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812-823. Go to original source...
  18. Lisy M, Kalender G, Schenke-Layland K et al. Allograft Heart Valves: Current Aspects and Future Applications. Biopreserv Biobank 2017;15:148-157. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.